Latest Tyrosine kinase receptors Stories
An estimated 19 million Americans suffer from depression, and though the symptoms might be recognizable, the brain chemistry that underlies them is incompletely understood.
Two sets of gene expression profiles predict response to a common lung cancer drug for patients that have no guiding indicators for their treatment now.
Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers.
For women with aggressive early-stage breast cancer (HER2-positive disease), trastuzumab (Herceptin) given for one year after chemotherapy proved to put the women at significantly less risk of the cancer returning.
Mice previously exposed to traumatic situations demonstrate a more persistent memory of fear conditioning - acquired by associating an acoustic stimulus with an aversive stimulus - and lack the ability to inhibit this fear.
Implications for blocking metastasis and improving responses to existing therapies.
SAN DIEGO, Dec. 7, 2010 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc.
Scientists believe they may have found a new target for treating triple negative breast cancer â€“ one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
PRINCETON, N.J., Oct.
Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment.